Mizuho Maintains Neutral on GoodRx Holdings, Lowers Price Target to $3
Benzinga Newsdesk 8 months ago
NewsPrice TargetAnalyst Ratings
Mizuho analyst Steven Valiquette maintains GoodRx Holdings (NASDAQ:GDRX) with a Neutral and lowers the price target from $4 to $3.
Mizuho analyst Steven Valiquette maintains GoodRx Holdings (NASDAQ:GDRX) with a Neutral and lowers the price target from $4 to $3.